The decision comes at a crucial juncture in the US's vaccination effort, which has gained speed in recent weeks at the same time a worsening outbreak grips the upper Midwest.
President Joe Biden described the approval as an encouraging development in efforts to end the Covid-19 crisis and said this is exciting news for all US citizens.
If J&J's phase 3 trial report very strong efficacy, it will be the single-shot vaccine that can be stored and transported at refrigerator temperatures unlike Pfizer and Moderna.
More than 90% of participants made immune proteins within 29 days after receiving the shot & all participants formed the antibodies within 57 days, according to the report.
The deal comes after a study showed Johnson & Johnson’s candidate vaccine generated strong antibody response in primates and provided protection with a single dose.
J&J announced in June that it had accelerated vaccine trials with ambitions of launching human studies in mid-July. The company will dose its first patients on 22 July in Belgium.
Through film, textile, scent, sound, and gesture, spectators are invited to descend into an immersive environment where inherited knowledge seeps through material and form.
November exports to the US saw 10% growth from the previous month. Overall, in the first 8 months this fiscal, the merchandise exports to the US touched has touched $59bn.
Of the total package, $649 million will be utilised for additional hardware, software, and support services, and the remaining for Major Defence Equipment (MDE).
Don’t blame misfortune. This is colossal incompetence and insensitivity. So bad, heads would have rolled even in the old PSU-era Indian Airlines and Air India.
COMMENTS